Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed
Food and Drug Administration · Department of Health and Human Services
At a glance
Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed is a forecasted federal cooperative agreement opportunity from the Food and Drug Administration (Department of Health and Human Services). The agency has forecast this opportunity but has not yet set an application deadline. Individual awards are listed as $250K, with about 1 award expected. The notice is unrestricted by applicant type, subject to any clarifications in the notice. Cost sharing is not required. It is funded under Assistance Listing 93.103 (Food and Drug Administration Research).
Summary assembled from the official notice's fields. The official notice governs.
Key facts
- Posted
- Aug 14, 2024
- Est. close date
- Not listed
- Award floor
- $250,000
- Award ceiling
- $250,000
- Est. total funding
- Not specified
- Expected awards
- 1
- Cost sharing
- Not required
- Funding instrument
- Cooperative Agreement
- Opportunity category
- Discretionary
- Fiscal year
- FY2025
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public colleges & universities
- Federally recognized tribal governments
- Public & Indian housing authorities
- Native American tribal organizations
- 501(c)(3) nonprofits
- Nonprofits without 501(c)(3) status
- Private colleges & universities
- For-profit organizations (not small businesses)
- Small businesses
- Unrestricted (any entity type)
A quick check against the listed applicant types — other requirements in the notice still apply.
Based on the published notice. Review the official notice for complete eligibility requirements.
What it funds
Official synopsis as published by the agency, formatted for readability.
The purpose of the funding opportunity is to expand and advance FDA's Office of Minority Health and Health Equity (OMHHE) work with stakeholders and partners for education, outreach, and public awareness activities on the use of and potential risks from skin lightening products (e.g., hydroquinone).
Applicants will propose innovative and community-based strategies and activities that have the potential to strengthen the science base for education and public health awareness on the use of and potential risks from skin lightening products.
How to apply
0 of 8 done · progress saved in this browser
Assistance Listing
What is an ALN?Reported obligations under ALN 93.103
Historical data · not a predictionAgency contact (as published)
Terrin Brown Grantor
terrin.brown@fda.hhs.gov
2404027610
Quick answers
Is this opportunity open for applications yet?
Not yet. It is a forecast — an agency's advance notice of an expected opportunity. Forecast details and dates can change.
Who is eligible to apply for this opportunity?
The notice lists eligibility as unrestricted — open to any type of entity — subject to clarifications in the notice's additional eligibility information.
How much funding is available through this opportunity?
Per the notice, individual awards are listed as $250k and the agency expects to make about 1 awards.
How do I apply for this opportunity?
Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity FOR-FD-25-013), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.
Related open opportunities
Matched on shared Assistance Listings, agency, categories and eligible applicant types.
Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
Food and Drug Administration- Award range
- Up to $900K
- Closes
- May 16, 2028
- Who can apply
- Others (see notice)
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
Food and Drug Administration- Award range
- Amount not specified
- Est. close
- Not yet set
- Who can apply
- Others (see notice)
REACHing Communities (REACH) Consortium (U01) Clinical Trials Optional
Food and Drug Administration- Award range
- $3M
- Est. close
- Not yet set
- Who can apply
- State governments, County governments, City or township governments and 12 more
Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed
Food and Drug Administration- Award range
- $2M
- Est. close
- Not yet set
- Who can apply
- State governments, County governments, City or township governments and 12 more
Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required
Food and Drug Administration- Award range
- $650K – $900K
- Est. close
- Not yet set
- Who can apply
- State governments, County governments, City or township governments and 12 more
Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed
Food and Drug Administration- Award range
- $1M
- Est. close
- Not yet set
- Who can apply
- State governments, County governments, City or township governments and 12 more